150
Participants
Start Date
July 25, 2022
Primary Completion Date
January 31, 2025
Study Completion Date
December 31, 2025
Frequent assessment of biomarker panel
During the eight-week inpatient follow-up period there will be daily follow-up of respiratory symptoms, vitals and spirometry, and a thrice weekly collection of spontaneous sputum, nasal swabs and venous blood. These assessments will be repeated at acute worsening of respiratory symptoms at which a stool sample will also be collected.
RECRUITING
Ciro, Horn
Collaborators (1)
AstraZeneca
INDUSTRY
Center of Expertise for Chronic Organ Failure
OTHER